本文已被:浏览 381次 下载 283次
投稿时间:2023-07-15
投稿时间:2023-07-15
中文摘要: γ-氨基丁酸(γ-aminobutyric acid,GABA)是一种重要的四碳非蛋白质氨基酸,具有改善睡眠质量、促进新陈代谢、降血压、降血糖等多种生理功能被应用于食品医药领域。目前,GABA 主要通过化学合成、植物富集及生物合成等方式获取,其中生物合成因安全性高、绿色环保、周期短、成本低而备受关注。但是生物合成GABA 仍存在一系列瓶颈问题限制其产量进一步提升,如缺乏高效底盘菌株、限速酶酶活性低、菌株与限速酶最适pH 值不兼容、从头合成底物利用率低、代谢压力影响菌株生长等。随着GABA 市场需求量不断增加,解决生物合成GABA 产量不足的问题迫在眉睫。该文聚焦当前GABA 生物合成及其产量提高策略,从筛选高产野生型菌株及诱变育种、构建辅酶因子回补途径、限速酶定向改造、代谢流重塑、多菌株共培养等方面进行综述,并对GABA 生物合成的机遇与挑战进行展望。
Abstract:As an important four-carbon non-protein amino acid,γ-aminobutyric acid(GABA)possesses multiple physiological functions,such as improving sleep,boosting metabolism,and lowering blood pressure,so it is widely used in food and medicine fields.Currently,GABA is mainly produced by chemical synthesis,plant enrichment,and biosynthesis.Among them,biosynthesis has attracted much attention due to high security,environmental friendliness,short period,and low cost.However,the biosynthesis of GABA still faces bottleneck problems,such as the lack of efficient chassis strain,low activity of the wild-type enzyme,incompatible pH environment between the strain and the rate-limiting enzyme,low substrate utilization rate of de novo synthesis,and metabolic pressure on strain growth.As the market demand for GABA is increasing,it is urgent to explore the measures for improving GABA production.The production of GABA by biosynthesis can be increased by screening high-yielding wild-type strains and mutagenesis breeding,construction of coenzyme factor complement pathway,directed modification of the rate-limiting enzyme,metabolic flux remodeling,and multi-strain co-culture.Furthermore,the future opportunities and challenges are prospected.
keywords: γ-aminobutyric acid biosynthesis production increase chassis strains rate-limiting enzyme metabolic flux
文章编号:202323024 中图分类号: 文献标志码:
基金项目:国家自然科学基金青年科学基金项目(32001792)
Author Name | Affiliation |
JIA Shijie,LIU Jianghua*,LI Guoliang* | School of Food Science and Engineering,Shaanxi University of Science&Technology,Xi'an 710021,Shaanxi,China |
引用文本: